FDA Inspection 1116226 — Hahnemann Laboratories, Inc.

Hahnemann Laboratories, Inc. — FEI 3001239031

The FDA completed an inspection of Hahnemann Laboratories, Inc. on January 28, 2020 in San Rafael, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 28, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Rafael, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
184421 CFR 211.84(d)(2)Establish reliability of supplier's C of A
185121 CFR 211.84(e)Rejecting When Specifications Not Met
189021 CFR 211.165(e)Test methods